Karyopharm Therapeutics

$0.00 (0.00%) As of 4:44 PM UTC today

Why Robinhood?

You can buy or sell KPTI and other stocks, options, and ETFs commission-free!

About KPTI

Karyopharm Therapeutics Inc. Common Stock, also called Karyopharm Therapeutics, is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases.

CEO
Richard A. Paulson
Employees
432
Headquarters
Newton, Massachusetts
Founded
2008

KPTI Key Statistics

Market Cap
694.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.74M
High Today
$9.37
Low Today
$8.90
Open Price
$9.22
Volume
904.02K
52 Week High
$21.82
52 Week Low
$7.78

KPTI Earnings

-$0.84
-$0.75
-$0.67
-$0.58
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.71 per share
Actual
-$0.77 per share
Replay Earnings Call

You May Also Like

WHFBZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure